Risk of Stroke in Patients with Rheumatism: A Nationwide Longitudinal Population-based Study
作者： Tsan-Hon Liou , Shih-Wei Huang , Jia-Wei Lin , Yu-Sheng Chang , Chin-Wen Wu
DOI: 10.1038/SREP05110
关键词:
摘要: The aim of this study was to investigate rheumatoid arthritis (RA), and systemic lupus erythematous (SLE) as risk factors for stroke. analyzed by Using the Taiwan Longitudinal Health Insurance Database 2005 (LHID2005), cohort investigated patients with a recorded diagnosis RA (N = 6114), SLE 621) between January 1, 2004, December 31, 2007, age-matched controls (1:4) (for RA, N 24456; SLE, 2484). We used Cox proportional-hazard regressions evaluate hazard ratios (HRs) after adjusting confounding factors. Our found 383 6114 patients, experienced stroke during 20267 person-year follow-up period. adjusted HR 1.24 (95% CI, 1.11 1.39), 1.88 1.08 3.27). When steroid added additional factor, ischemic 1.32 1.15 1.50), 1.31 0.51 3.34). In conclusion, rheumatic diseases are all After controlled effect prescription, is factor
nature.com
harvard.edu
elsevier.com
researchgate.net 
sci-hub.se 参考文章(43)
Solveig Wållberg-Jonsson, Birgitta Stegmayr, Anna Södergren, Marie-Louise Öhman, Increased incidence of stroke and impaired prognosis after stroke among patients with seropositive rheumatoid arthritis Clinical and Experimental Rheumatology. ,vol. 27, pp. 641- 644 ,(2009)
David R. Cox, Regression Models and Life-Tables Springer Series in Statistics. ,vol. 34, pp. 527- 541 ,(1992) , 10.1007/978-1-4612-4380-9_37
Po-Chih Chen, Teng-chu Tseng, Jui-Yang Hsieh, Hui-Wen Lin, Association Between Stroke and Patients With Pelvic Inflammatory Disease Stroke. ,vol. 42, pp. 2074- 2076 ,(2011) , 10.1161/STROKEAHA.110.612655
Patricia McGettigan, David Henry, Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies. PLOS Medicine. ,vol. 8, ,(2011) , 10.1371/JOURNAL.PMED.1001098
Peter Libby, Role of inflammation in atherosclerosis associated with rheumatoid arthritis. The American Journal of Medicine. ,vol. 121, ,(2008) , 10.1016/J.AMJMED.2008.06.014
Fernando Gonzales-Portillo, John A. McIntyre, Dawn R. Wagenknecht, Linda S. Williams, Askiel Bruno, José Biller, Spectrum of Antiphospholipid Antibodies (aPL) in Patients With Cerebrovascular Disease Journal of Stroke & Cerebrovascular Diseases. ,vol. 10, pp. 222- 226 ,(2001) , 10.1053/JSCD.2001.29818
A. Blohorn, E. Guegan-Massardier, A. Triquenot, Y. Onnient, F. Tron, J.Y. Borg, B. Mihout, Antiphospholipid antibodies in the acute phase of cerebral ischaemia in young adults: a descriptive study of 139 patients. Cerebrovascular Diseases. ,vol. 13, pp. 156- 162 ,(2002) , 10.1159/000047769
Daniel H. Solomon, Jerry Avorn, Jeffrey N. Katz, Michael E. Weinblatt, Soko Setoguchi, Raisa Levin, Sebastian Schneeweiss, Immunosuppressive Medications and Hospitalization for Cardiovascular Events in Patients With Rheumatoid Arthritis Arthritis & Rheumatism. ,vol. 54, pp. 3790- 3798 ,(2006) , 10.1002/ART.22255
Jaime Calvo-Alén, Graciela S. Alarcón, Monty B. Tew, Filemon K. Tan, Gerald McGwin, Barri J. Fessler, Luis M. Vilá, John D. Reveille, , Systemic lupus erythematosus in a multiethnic US cohort: XXXIV. Deficient mannose-binding lectin exon 1 polymorphisms are associated with cerebrovascular but not with other arterial thrombotic events. Arthritis & Rheumatism. ,vol. 54, pp. 1940- 1945 ,(2006) , 10.1002/ART.21787
Andrew C. Newby, Metalloproteinases and vulnerable atherosclerotic plaques. Trends in Cardiovascular Medicine. ,vol. 17, pp. 253- 258 ,(2007) , 10.1016/J.TCM.2007.09.001